Polypill revisited - Unity in diversity.
作者信息
Dan Gheorghe-Andrei, Dobrev Dobromir
机构信息
"Carol Davila" University of Medicine, Colentina University Hospital, Bucharest, Romania.
Institute of Pharmacology, Faculty of Medicine, University Duisburg-Essen, Germany.
出版信息
Int J Cardiol Heart Vasc. 2020 Aug 10;29:100607. doi: 10.1016/j.ijcha.2020.100607. eCollection 2020 Aug.
Abstract
摘要
相似文献
1
Polypill revisited - Unity in diversity.复方制剂再探讨——多样中的统一
Int J Cardiol Heart Vasc. 2020 Aug 10;29:100607. doi: 10.1016/j.ijcha.2020.100607. eCollection 2020 Aug.
2
[Two decades later, the polypill revisited].[二十年后，再探多效药丸]
Rev Prat. 2021 Sep;71(7):713-716.
3
Evaluating patients' satisfaction and preferences with a secondary prevention cardiovascular polypill: the Aurora Study.评估患者对二级预防心血管复方药的满意度和偏好：Aurora 研究。
J Comp Eff Res. 2021 Sep;10(13):975-985. doi: 10.2217/cer-2021-0105. Epub 2021 Jul 1.
4
What is the future of stroke prevention?: debate: polypill versus personalized risk factor modification.未来的卒中预防策略如何？辩论：多效药丸与个体化危险因素修正。
Stroke. 2010 Oct;41(10 Suppl):S35-8. doi: 10.1161/STROKEAHA.110.592022.
5
Can a polypill one single tablet combat different cardiovascular risk factors?一片复方制剂能对抗多种心血管危险因素吗？
J Am Soc Hypertens. 2018 May;12(5):335-339. doi: 10.1016/j.jash.2018.02.008. Epub 2018 Mar 2.
6
Fixed Dose Combination Therapy for Secondary Prevention of Major Cardiovascular Events: Review of Literature and Design for Persian Polypill, A Randomized Clinical Trial.固定剂量复方疗法用于主要心血管事件的二级预防：文献综述及波斯复方药丸的设计，一项随机临床试验
Curr Probl Cardiol. 2022 Jun;47(6):100872. doi: 10.1016/j.cpcardiol.2021.100872. Epub 2021 Apr 20.
7
Strengths and Limitations of Using the Polypill in Cardiovascular Prevention.使用复方制剂进行心血管疾病预防的优势与局限
Curr Cardiol Rep. 2017 May;19(5):45. doi: 10.1007/s11886-017-0853-y.
8
Biochemical unity revisited: microbial central carbon metabolism holds new discoveries, multi-tasking pathways, and redundancies with a reason.重新审视生物化学的统一性：微生物中心碳代谢蕴含着新的发现、多任务处理途径以及具有合理性的冗余。
Biol Chem. 2020 Nov 26;401(12):1429-1441. doi: 10.1515/hsz-2020-0214.
9
The polypill: a potential global solution to cardiovascular disease.复方药丸：解决心血管疾病的潜在全球方案。
Cardiol Rev. 2013 Jan-Feb;21(1):49-54. doi: 10.1097/CRD.0b013e3182755429.
10
A polypill strategy to improve global secondary cardiovascular prevention: from concept to reality.多药复方策略改善全球心血管二级预防：从概念到现实。
J Am Coll Cardiol. 2014 Aug 12;64(6):613-21. doi: 10.1016/j.jacc.2014.06.009.
本文引用的文献
1
The CNIC-polypill improves atherogenic dyslipidemia markers in patients at high risk or with cardiovascular disease: Results from a real-world setting in Mexico.CNIC复合制剂可改善高危或患有心血管疾病患者的致动脉粥样硬化血脂异常标志物：来自墨西哥真实环境的结果。
Int J Cardiol Heart Vasc. 2020 Jun 3;29:100545. doi: 10.1016/j.ijcha.2020.100545. eCollection 2020 Aug.
2
Implementation Strategies for Cardiovascular Polypills.心血管复方制剂的实施策略
JAMA. 2019 Dec 17;322(23):2279-2280. doi: 10.1001/jama.2019.18102.
3
Polypill for Cardiovascular Disease Prevention in an Underserved Population.用于服务不足人群心血管疾病预防的复方药。
N Engl J Med. 2019 Sep 19;381(12):1114-1123. doi: 10.1056/NEJMoa1815359.
4
Six Month Polypill Therapy Improves Lipid Profile in Patients with Previous Acute Myocardial Infarction: The Heart-Mex Study.六效复方药治疗可改善既往急性心肌梗死患者的血脂水平：HEART-MEX 研究。
Arch Med Res. 2019 May;50(4):197-206. doi: 10.1016/j.arcmed.2019.08.002. Epub 2019 Sep 26.
5
Effectiveness of polypill for primary and secondary prevention of cardiovascular diseases (PolyIran): a pragmatic, cluster-randomised trial.多酚丸用于心血管疾病一级和二级预防的效果（PolyIran）：一项实用、整群随机试验。
Lancet. 2019 Aug 24;394(10199):672-683. doi: 10.1016/S0140-6736(19)31791-X.
6
The polypill in cardiovascular prevention: evidence, limitations and perspective - position paper of the European Society of Hypertension.心血管疾病预防中的多效药丸：证据、局限性与展望——欧洲高血压学会立场文件
J Hypertens. 2017 Aug;35(8):1546-1553. doi: 10.1097/HJH.0000000000001390.
7
Fixed-dose combination therapy for the prevention of atherosclerotic cardiovascular diseases.用于预防动脉粥样硬化性心血管疾病的固定剂量联合疗法。
Cochrane Database Syst Rev. 2017 Mar 6;3(3):CD009868. doi: 10.1002/14651858.CD009868.pub3.
8
Reducing Premature Cardiovascular Morbidity and Mortality in People With Atherosclerotic Vascular Disease: The World Heart Federation Roadmap for Secondary Prevention of Cardiovascular Disease.降低动脉粥样硬化性血管疾病患者的心血管疾病过早发病和死亡风险：世界心脏联盟心血管疾病二级预防路线图
Glob Heart. 2015 Jun;10(2):99-110. doi: 10.1016/j.gheart.2015.04.003.
9
A polypill strategy to improve adherence: results from the FOCUS project.多药复方片策略提高依从性：FOCUS 项目结果。
J Am Coll Cardiol. 2014;64(20):2071-82. doi: 10.1016/j.jacc.2014.08.021. Epub 2014 Sep 1.
Zotero 插件